Oxford Asset Management’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-34,603
Closed -$946K 802
2015
Q1
$946K Buy
+34,603
New +$953K 0.02% 470
2014
Q1
Sell
-98,130
Closed -$3.57M 863
2013
Q4
$3.57M Sell
98,130
-158,560
-62% -$6.16M 0.09% 307
2013
Q3
$9.98M Buy
256,690
+184,356
+255% +$7.43M 0.22% 97
2013
Q2
$2.71M Buy
+72,334
New +$2.86M 0.07% 400

Other funds holding MR

Oxford Asset Management's MR Position: Q2 2015 in Review

Oxford Asset Management sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q2 2015, closing a stake of 34,603 shares — an estimated $946K sold.

Oxford Asset Management first reported a position in MR in Q2 2013 and held it in 4 quarters. The position peaked at $9.98M in Q3 2013. 118 funds tracked by Wall St. Rank hold MR as of Q2 2015.

  • Oxford Asset Management reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q2 2015 after selling out during the quarter.
  • Oxford Asset Management sold 34,603 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q2 2015, an estimated $946K.
  • Oxford Asset Management first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 4 quarters.
  • Oxford Asset Management's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $9.98M in Q3 2013.
  • 118 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q2 2015.

Based on Oxford Asset Management's 13F filing for Q2 2015, filed 11 Aug 2015.